Cargando…
Chidamide in the treatment of peripheral T-cell lymphoma
Mature T-cell lymphomas are aggressive malignancies. Treatment outcome is poor with conventional chemotherapy. They are about twice as common in Asia as compared with other non-Asian countries. Histone proteins form the basic structure of chromatin, and their acetylation at lysine residues relaxes c...
Autores principales: | Chan, Thomas S, Tse, Eric, Kwong, Yok-Lam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238768/ https://www.ncbi.nlm.nih.gov/pubmed/28138258 http://dx.doi.org/10.2147/OTT.S93528 |
Ejemplares similares
-
The diagnosis and management of NK/T-cell lymphomas
por: Tse, Eric, et al.
Publicado: (2017) -
How we treat NK/T-cell lymphomas
por: Tse, Eric, et al.
Publicado: (2022) -
Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies
por: Tse, Eric, et al.
Publicado: (2022) -
Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma
por: Wang, Jinni, et al.
Publicado: (2022) -
The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review
por: Ridwansyah, Hastono, et al.
Publicado: (2023)